167 related articles for article (PubMed ID: 34724199)
21. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients.
Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C
PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity.
Chernyshov PV
G Ital Dermatol Venereol; 2016 Feb; 151(1):37-43. PubMed ID: 24927171
[TBL] [Abstract][Full Text] [Related]
23. Discrepancies between the Dermatology Life Quality Index and utility scores.
Rencz F; Baji P; Gulácsi L; Kárpáti S; Péntek M; Poór AK; Brodszky V
Qual Life Res; 2016 Jul; 25(7):1687-96. PubMed ID: 26684848
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
[TBL] [Abstract][Full Text] [Related]
25. "DLQI Seems to be 'Action', and Skindex-29 Seems to be 'Emotion'": Qualitative Study of the Perceptions of Patients with Psoriasis or Eczema on Two Common Dermatology-specific Quality of Life Measures.
Paudyal P; Apfelbacher C; Jones C; Siddiqui S; El-Turki A; DeGiovanni C; Smith H
Acta Derm Venereol; 2020 Apr; 100(8):adv00105. PubMed ID: 32020205
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Skindex-17 quality of life assessment instrument for a Brazilian population.
Jorge MFS; Mourão IB; Pollo CF; Sousa TD; Meneguin S; Miot HA
An Bras Dermatol; 2021; 96(1):51-58. PubMed ID: 33281012
[TBL] [Abstract][Full Text] [Related]
27. Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.
Krain RL; Kushner CJ; Tarazi M; Gaffney RG; Yeguez AC; Zamalin DE; Pearson DR; Feng R; Payne AS; Werth VP
Front Immunol; 2019; 10():2571. PubMed ID: 31781098
[TBL] [Abstract][Full Text] [Related]
28. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
29. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.
Rogers A; DeLong LK; Chen SC
Dermatol Clin; 2012 Apr; 30(2):333-42, x. PubMed ID: 22284147
[TBL] [Abstract][Full Text] [Related]
30. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic.
Hahn HB; Melfi CA; Chuang TY; Lewis CW; Gonin R; Hanna MP; Farmer ER
J Am Acad Dermatol; 2001 Jul; 45(1):44-8. PubMed ID: 11423833
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.
Gupta V; Taneja N; Sati HC; Sreenivas V; Ramam M
Br J Dermatol; 2021 Jan; 184(1):168-169. PubMed ID: 32730641
[No Abstract] [Full Text] [Related]
33. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
34. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
35. Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark.
Tennvall GR; Norlin JM; Malmberg I; Erlendsson AM; Hædersdal M
Health Qual Life Outcomes; 2015 Jul; 13():111. PubMed ID: 26220553
[TBL] [Abstract][Full Text] [Related]
36. Cross validation of the Turkish version of dermatology life quality index.
Oztürkcan S; Ermertcan AT; Eser E; Sahin MT
Int J Dermatol; 2006 Nov; 45(11):1300-7. PubMed ID: 17076710
[TBL] [Abstract][Full Text] [Related]
37. Is the DLQI appropriate for medical decision-making in psoriasis patients?
Poór AK; Brodszky V; Péntek M; Gulácsi L; Ruzsa G; Hidvégi B; Holló P; Kárpáti S; Sárdy M; Rencz F
Arch Dermatol Res; 2018 Jan; 310(1):47-55. PubMed ID: 29128966
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
39. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.
Bató A; Brodszky V; Gergely LH; Gáspár K; Wikonkál N; Kinyó Á; Szabó Á; Beretzky Z; Szegedi A; Remenyik É; Kiss N; Sárdy M; Rencz F
Qual Life Res; 2021 May; 30(5):1477-1490. PubMed ID: 33534032
[TBL] [Abstract][Full Text] [Related]
40. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
